| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 183 | 2024 | 12143 | 7.080 |
Why?
|
| Life Style | 67 | 2024 | 3907 | 3.630 |
Why?
|
| Obesity | 95 | 2024 | 12934 | 3.390 |
Why?
|
| Blood Glucose | 70 | 2024 | 6390 | 3.000 |
Why?
|
| Polymorphism, Single Nucleotide | 121 | 2024 | 15908 | 2.950 |
Why?
|
| Metformin | 27 | 2023 | 906 | 2.750 |
Why?
|
| Motor Activity | 36 | 2017 | 2714 | 2.660 |
Why?
|
| Genome-Wide Association Study | 92 | 2024 | 12661 | 2.400 |
Why?
|
| Prediabetic State | 16 | 2024 | 545 | 2.390 |
Why?
|
| Genetic Loci | 25 | 2021 | 2624 | 2.280 |
Why?
|
| Genetic Predisposition to Disease | 86 | 2024 | 17878 | 2.140 |
Why?
|
| Exercise | 43 | 2022 | 5886 | 2.040 |
Why?
|
| Body Mass Index | 83 | 2024 | 12942 | 1.990 |
Why?
|
| Genotype | 76 | 2022 | 12977 | 1.980 |
Why?
|
| Insulin | 47 | 2023 | 6593 | 1.870 |
Why?
|
| Energy Metabolism | 36 | 2020 | 2878 | 1.780 |
Why?
|
| Cardiovascular Diseases | 38 | 2023 | 15498 | 1.700 |
Why?
|
| Genetic Variation | 40 | 2024 | 6561 | 1.690 |
Why?
|
| Sweden | 30 | 2022 | 1379 | 1.590 |
Why?
|
| Insulin Resistance | 35 | 2024 | 3954 | 1.460 |
Why?
|
| Diabetes Mellitus | 21 | 2024 | 5838 | 1.450 |
Why?
|
| Diet | 39 | 2024 | 8049 | 1.380 |
Why?
|
| Physical Fitness | 15 | 2017 | 743 | 1.320 |
Why?
|
| Emigrants and Immigrants | 5 | 2017 | 544 | 1.280 |
Why?
|
| Body Composition | 17 | 2021 | 2426 | 1.260 |
Why?
|
| Fasting | 27 | 2024 | 1603 | 1.230 |
Why?
|
| Lipids | 18 | 2023 | 3332 | 1.210 |
Why?
|
| Humans | 496 | 2024 | 760740 | 1.190 |
Why?
|
| Europe | 49 | 2022 | 3415 | 1.180 |
Why?
|
| Blood Pressure | 29 | 2020 | 8473 | 1.170 |
Why?
|
| Triglycerides | 22 | 2023 | 2459 | 1.170 |
Why?
|
| Adiposity | 17 | 2024 | 1879 | 1.120 |
Why?
|
| Heat-Shock Proteins | 6 | 2009 | 795 | 1.120 |
Why?
|
| Hypertension | 26 | 2022 | 8532 | 1.070 |
Why?
|
| Glucose Intolerance | 10 | 2021 | 575 | 1.050 |
Why?
|
| Energy Intake | 20 | 2023 | 2133 | 1.030 |
Why?
|
| Glucose Tolerance Test | 23 | 2021 | 1178 | 1.030 |
Why?
|
| Genomics | 17 | 2023 | 5822 | 1.020 |
Why?
|
| Risk Factors | 125 | 2023 | 74128 | 1.000 |
Why?
|
| Female | 316 | 2024 | 392203 | 0.960 |
Why?
|
| Middle Aged | 231 | 2024 | 220603 | 0.920 |
Why?
|
| Waist Circumference | 19 | 2022 | 933 | 0.920 |
Why?
|
| Body Height | 10 | 2022 | 1565 | 0.920 |
Why?
|
| Adult | 228 | 2024 | 220995 | 0.910 |
Why?
|
| Risk Reduction Behavior | 8 | 2017 | 1110 | 0.890 |
Why?
|
| Male | 284 | 2024 | 360402 | 0.880 |
Why?
|
| Multifactorial Inheritance | 9 | 2024 | 1381 | 0.860 |
Why?
|
| Hypoglycemic Agents | 18 | 2022 | 3085 | 0.850 |
Why?
|
| Body Weight | 18 | 2019 | 4615 | 0.850 |
Why?
|
| Cholesterol, HDL | 14 | 2020 | 1810 | 0.830 |
Why?
|
| Postprandial Period | 9 | 2023 | 314 | 0.830 |
Why?
|
| Polymorphism, Genetic | 19 | 2019 | 4242 | 0.820 |
Why?
|
| Adipocytes, White | 1 | 2023 | 90 | 0.820 |
Why?
|
| Weight Loss | 16 | 2023 | 2682 | 0.820 |
Why?
|
| Quantitative Trait Loci | 20 | 2022 | 2112 | 0.810 |
Why?
|
| Fatty Acids, Nonesterified | 4 | 2008 | 393 | 0.780 |
Why?
|
| Arabs | 2 | 2014 | 187 | 0.770 |
Why?
|
| Organic Cation Transport Proteins | 3 | 2022 | 61 | 0.770 |
Why?
|
| Gene Frequency | 21 | 2024 | 3601 | 0.760 |
Why?
|
| Glucose | 14 | 2023 | 4345 | 0.760 |
Why?
|
| Lipogenesis | 1 | 2023 | 214 | 0.750 |
Why?
|
| Cholesterol, LDL | 14 | 2022 | 2378 | 0.750 |
Why?
|
| Dietary Fats | 13 | 2020 | 1995 | 0.740 |
Why?
|
| Smoking | 17 | 2019 | 9054 | 0.700 |
Why?
|
| Indians, North American | 8 | 2011 | 351 | 0.700 |
Why?
|
| Prospective Studies | 77 | 2023 | 54364 | 0.690 |
Why?
|
| Homeostasis | 7 | 2020 | 3321 | 0.680 |
Why?
|
| Phenotype | 34 | 2023 | 16572 | 0.670 |
Why?
|
| Cohort Studies | 80 | 2024 | 41464 | 0.670 |
Why?
|
| Family Practice | 11 | 2000 | 507 | 0.660 |
Why?
|
| Genetic Association Studies | 16 | 2019 | 2734 | 0.650 |
Why?
|
| Leptin | 7 | 2016 | 1595 | 0.650 |
Why?
|
| Overweight | 11 | 2019 | 2417 | 0.650 |
Why?
|
| Insulin-Secreting Cells | 8 | 2024 | 898 | 0.630 |
Why?
|
| Mortality | 13 | 2020 | 2899 | 0.620 |
Why?
|
| Transcription Factors | 11 | 2019 | 12116 | 0.610 |
Why?
|
| Hyperglycemia | 5 | 2017 | 1375 | 0.610 |
Why?
|
| Pregnancy | 37 | 2023 | 29869 | 0.600 |
Why?
|
| Receptor, Melatonin, MT2 | 2 | 2015 | 82 | 0.590 |
Why?
|
| Proteins | 11 | 2019 | 6030 | 0.580 |
Why?
|
| Hypertriglyceridemia | 5 | 2016 | 293 | 0.570 |
Why?
|
| Alleles | 28 | 2023 | 6861 | 0.570 |
Why?
|
| Checklist | 1 | 2024 | 827 | 0.570 |
Why?
|
| Mendelian Randomization Analysis | 16 | 2024 | 1007 | 0.560 |
Why?
|
| Consensus | 3 | 2023 | 3117 | 0.560 |
Why?
|
| Coronary Artery Disease | 14 | 2022 | 6403 | 0.560 |
Why?
|
| Metabolic Diseases | 3 | 2018 | 680 | 0.550 |
Why?
|
| Salivary alpha-Amylases | 1 | 2016 | 15 | 0.550 |
Why?
|
| Oxygen Consumption | 10 | 2008 | 1866 | 0.550 |
Why?
|
| Biological Specimen Banks | 4 | 2019 | 778 | 0.540 |
Why?
|
| Glucose Metabolism Disorders | 2 | 2021 | 52 | 0.530 |
Why?
|
| Health Status | 12 | 2018 | 4076 | 0.530 |
Why?
|
| PPAR gamma | 5 | 2018 | 484 | 0.530 |
Why?
|
| Epistasis, Genetic | 4 | 2020 | 350 | 0.520 |
Why?
|
| Aged | 119 | 2024 | 169092 | 0.520 |
Why?
|
| Cholesterol | 6 | 2023 | 2902 | 0.510 |
Why?
|
| Intra-Abdominal Fat | 4 | 2022 | 612 | 0.500 |
Why?
|
| Hypertension, Pregnancy-Induced | 5 | 2018 | 517 | 0.490 |
Why?
|
| Cryptochromes | 1 | 2015 | 48 | 0.490 |
Why?
|
| Bicycling | 1 | 2016 | 177 | 0.490 |
Why?
|
| Endocrinology | 2 | 2020 | 442 | 0.490 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2022 | 2872 | 0.480 |
Why?
|
| Membrane Proteins | 13 | 2021 | 7847 | 0.480 |
Why?
|
| Sleep Deprivation | 1 | 2021 | 847 | 0.480 |
Why?
|
| Cross-Sectional Studies | 44 | 2024 | 26065 | 0.480 |
Why?
|
| Residence Characteristics | 5 | 2020 | 2092 | 0.470 |
Why?
|
| Incidence | 41 | 2024 | 21339 | 0.460 |
Why?
|
| Periodontitis | 2 | 2019 | 568 | 0.460 |
Why?
|
| Physicians, Family | 5 | 2001 | 348 | 0.460 |
Why?
|
| Maternal-Fetal Relations | 1 | 2014 | 25 | 0.460 |
Why?
|
| Environment | 4 | 2009 | 1123 | 0.460 |
Why?
|
| Fatty Liver | 1 | 2020 | 787 | 0.450 |
Why?
|
| Leukocytes | 5 | 2020 | 2024 | 0.440 |
Why?
|
| Odds Ratio | 17 | 2020 | 9644 | 0.430 |
Why?
|
| Gold | 1 | 2017 | 481 | 0.430 |
Why?
|
| Birth Weight | 5 | 2021 | 2101 | 0.420 |
Why?
|
| Apolipoprotein A-I | 1 | 2014 | 299 | 0.420 |
Why?
|
| Heterozygote | 3 | 2018 | 2780 | 0.420 |
Why?
|
| DNA Methylation | 6 | 2023 | 4392 | 0.420 |
Why?
|
| Diabetes, Gestational | 5 | 2022 | 1250 | 0.420 |
Why?
|
| Chromosome Mapping | 8 | 2022 | 4611 | 0.410 |
Why?
|
| Dyslipidemias | 3 | 2018 | 868 | 0.400 |
Why?
|
| Diabetes Complications | 5 | 2023 | 1315 | 0.400 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2021 | 540 | 0.400 |
Why?
|
| Tobacco, Smokeless | 1 | 2013 | 133 | 0.400 |
Why?
|
| Dental Caries | 4 | 2020 | 427 | 0.400 |
Why?
|
| Adiponectin | 6 | 2016 | 1107 | 0.390 |
Why?
|
| Case-Control Studies | 38 | 2021 | 22153 | 0.390 |
Why?
|
| Iraq | 4 | 2017 | 92 | 0.390 |
Why?
|
| Waist-Hip Ratio | 13 | 2022 | 518 | 0.390 |
Why?
|
| Adipokines | 1 | 2014 | 308 | 0.390 |
Why?
|
| Dietary Carbohydrates | 7 | 2020 | 891 | 0.390 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 262 | 0.390 |
Why?
|
| Linkage Disequilibrium | 12 | 2024 | 1994 | 0.380 |
Why?
|
| Weight Gain | 6 | 2017 | 2349 | 0.380 |
Why?
|
| Proprotein Convertase 1 | 3 | 2015 | 10 | 0.370 |
Why?
|
| Heart Rate | 16 | 2015 | 4181 | 0.370 |
Why?
|
| Adipose Tissue | 18 | 2021 | 3310 | 0.370 |
Why?
|
| Hand Strength | 3 | 2019 | 456 | 0.370 |
Why?
|
| Income | 7 | 2023 | 1870 | 0.370 |
Why?
|
| Deafness | 3 | 1999 | 459 | 0.370 |
Why?
|
| Receptors, Nicotinic | 2 | 2015 | 495 | 0.370 |
Why?
|
| Publications | 1 | 2013 | 194 | 0.360 |
Why?
|
| Primary Health Care | 12 | 2009 | 4677 | 0.360 |
Why?
|
| Cyclin-Dependent Kinase 5 | 2 | 2010 | 112 | 0.360 |
Why?
|
| Receptor, Melanocortin, Type 4 | 3 | 2017 | 129 | 0.360 |
Why?
|
| Fatty Acids | 6 | 2023 | 1808 | 0.350 |
Why?
|
| Risk Assessment | 19 | 2020 | 23974 | 0.350 |
Why?
|
| Biomedical Research | 4 | 2024 | 3426 | 0.350 |
Why?
|
| Obesity, Abdominal | 2 | 2011 | 373 | 0.350 |
Why?
|
| Metabolomics | 4 | 2024 | 1656 | 0.350 |
Why?
|
| Gastric Inhibitory Polypeptide | 2 | 2020 | 68 | 0.350 |
Why?
|
| Seasons | 2 | 2020 | 1518 | 0.350 |
Why?
|
| Anthropometry | 10 | 2019 | 1338 | 0.340 |
Why?
|
| Patient Selection | 4 | 2018 | 4237 | 0.340 |
Why?
|
| Glucagon-Like Peptide 1 | 3 | 2024 | 364 | 0.340 |
Why?
|
| Sleep | 3 | 2023 | 4764 | 0.340 |
Why?
|
| Lipid Metabolism | 7 | 2021 | 1896 | 0.340 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 4 | 1999 | 64 | 0.340 |
Why?
|
| Apolipoproteins E | 2 | 2016 | 1443 | 0.330 |
Why?
|
| Proportional Hazards Models | 30 | 2020 | 12448 | 0.330 |
Why?
|
| Feeding Behavior | 10 | 2023 | 3183 | 0.320 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2022 | 467 | 0.320 |
Why?
|
| Vaginal Smears | 3 | 2014 | 499 | 0.310 |
Why?
|
| Acceleration | 4 | 2013 | 189 | 0.310 |
Why?
|
| DNA Copy Number Variations | 2 | 2016 | 2020 | 0.310 |
Why?
|
| Monitoring, Physiologic | 3 | 2015 | 1780 | 0.300 |
Why?
|
| Body Fat Distribution | 6 | 2019 | 245 | 0.300 |
Why?
|
| Evidence-Based Medicine | 5 | 2023 | 3680 | 0.300 |
Why?
|
| Anti-Obesity Agents | 1 | 2011 | 227 | 0.300 |
Why?
|
| Hydronephrosis | 1 | 2009 | 271 | 0.290 |
Why?
|
| Mental Health | 4 | 2020 | 3253 | 0.290 |
Why?
|
| Health Maintenance Organizations | 4 | 1999 | 658 | 0.290 |
Why?
|
| United States | 51 | 2022 | 72292 | 0.290 |
Why?
|
| Cardiovascular Physiological Phenomena | 3 | 2019 | 241 | 0.290 |
Why?
|
| Chromans | 1 | 2007 | 117 | 0.290 |
Why?
|
| Sex Factors | 20 | 2021 | 10549 | 0.290 |
Why?
|
| Socioeconomic Factors | 17 | 2023 | 7805 | 0.280 |
Why?
|
| Ascorbic Acid | 2 | 2020 | 655 | 0.280 |
Why?
|
| Eating | 5 | 2022 | 1535 | 0.280 |
Why?
|
| Epigenesis, Genetic | 6 | 2022 | 3794 | 0.280 |
Why?
|
| Predictive Value of Tests | 11 | 2021 | 15250 | 0.280 |
Why?
|
| Gene Expression Regulation | 10 | 2020 | 11874 | 0.270 |
Why?
|
| Subcutaneous Fat | 1 | 2010 | 393 | 0.270 |
Why?
|
| Genes | 2 | 2012 | 1823 | 0.270 |
Why?
|
| Health Surveys | 7 | 2017 | 4036 | 0.270 |
Why?
|
| Educational Status | 8 | 2012 | 2509 | 0.270 |
Why?
|
| Coffee | 2 | 2022 | 592 | 0.270 |
Why?
|
| Dietary Proteins | 4 | 2020 | 951 | 0.260 |
Why?
|
| Adolescent | 54 | 2021 | 88247 | 0.260 |
Why?
|
| Amino Acid Substitution | 2 | 2007 | 1739 | 0.260 |
Why?
|
| Misoprostol | 5 | 1999 | 93 | 0.260 |
Why?
|
| Guidelines as Topic | 2 | 2024 | 1386 | 0.260 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2016 | 540 | 0.260 |
Why?
|
| Abortion, Induced | 5 | 1999 | 461 | 0.250 |
Why?
|
| Meta-Analysis as Topic | 6 | 2017 | 1380 | 0.250 |
Why?
|
| Prescriptions | 1 | 2008 | 386 | 0.250 |
Why?
|
| Basal Metabolism | 2 | 2006 | 161 | 0.250 |
Why?
|
| Prevalence | 11 | 2023 | 15702 | 0.250 |
Why?
|
| Vitamin D | 4 | 2021 | 3301 | 0.250 |
Why?
|
| Follow-Up Studies | 34 | 2022 | 39062 | 0.240 |
Why?
|
| Absorptiometry, Photon | 7 | 2016 | 1738 | 0.240 |
Why?
|
| Fruit | 5 | 2020 | 1158 | 0.240 |
Why?
|
| Denmark | 10 | 2020 | 770 | 0.240 |
Why?
|
| Iron | 3 | 2019 | 1790 | 0.240 |
Why?
|
| Phospholipids | 3 | 2023 | 787 | 0.240 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2014 | 2020 | 0.240 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2004 | 29 | 0.240 |
Why?
|
| Telomere | 3 | 2020 | 942 | 0.240 |
Why?
|
| Young Adult | 28 | 2022 | 59191 | 0.240 |
Why?
|
| Specialization | 3 | 1998 | 778 | 0.240 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2006 | 361 | 0.240 |
Why?
|
| Tea | 2 | 2019 | 287 | 0.240 |
Why?
|
| C-Peptide | 3 | 2021 | 440 | 0.240 |
Why?
|
| Age of Onset | 7 | 2018 | 3303 | 0.230 |
Why?
|
| Thiazolidinediones | 1 | 2007 | 460 | 0.230 |
Why?
|
| Referral and Consultation | 6 | 2000 | 3599 | 0.230 |
Why?
|
| Leiomyoma | 1 | 2009 | 636 | 0.230 |
Why?
|
| Middle East | 2 | 2015 | 231 | 0.230 |
Why?
|
| Internationality | 2 | 2022 | 1000 | 0.230 |
Why?
|
| Environmental Exposure | 3 | 2016 | 4483 | 0.230 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2018 | 1390 | 0.230 |
Why?
|
| Finland | 4 | 2020 | 607 | 0.230 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2019 | 512 | 0.230 |
Why?
|
| Pre-Eclampsia | 3 | 2018 | 1230 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7390 | 0.220 |
Why?
|
| Risk | 16 | 2018 | 9603 | 0.220 |
Why?
|
| Muscle, Skeletal | 5 | 2013 | 4947 | 0.220 |
Why?
|
| Muscle, Smooth | 1 | 2007 | 927 | 0.220 |
Why?
|
| Physical Education and Training | 1 | 2003 | 102 | 0.210 |
Why?
|
| Adipocytes, Brown | 1 | 2024 | 150 | 0.210 |
Why?
|
| Bariatric Surgery | 2 | 2023 | 992 | 0.210 |
Why?
|
| Sex Characteristics | 8 | 2022 | 2637 | 0.210 |
Why?
|
| Genetic Markers | 3 | 2016 | 2601 | 0.210 |
Why?
|
| New York | 9 | 2000 | 875 | 0.210 |
Why?
|
| Muscular Diseases | 1 | 2007 | 552 | 0.210 |
Why?
|
| Cation Transport Proteins | 4 | 2014 | 327 | 0.210 |
Why?
|
| Niacin | 1 | 2023 | 118 | 0.210 |
Why?
|
| Nutritional Status | 4 | 2022 | 1597 | 0.210 |
Why?
|
| Alcohol Drinking | 4 | 2019 | 4028 | 0.210 |
Why?
|
| Vegetables | 3 | 2020 | 1192 | 0.210 |
Why?
|
| Diet, Mediterranean | 3 | 2023 | 738 | 0.210 |
Why?
|
| Pregnant Women | 3 | 2023 | 567 | 0.210 |
Why?
|
| Appetite | 2 | 2023 | 247 | 0.210 |
Why?
|
| Meat | 3 | 2015 | 584 | 0.210 |
Why?
|
| Leg Ulcer | 2 | 2001 | 71 | 0.210 |
Why?
|
| Health Status Indicators | 5 | 2001 | 970 | 0.200 |
Why?
|
| Inflammation | 8 | 2023 | 10759 | 0.200 |
Why?
|
| Dairy Products | 2 | 2019 | 490 | 0.200 |
Why?
|
| Quality of Life | 3 | 2020 | 13359 | 0.200 |
Why?
|
| Beverages | 4 | 2017 | 821 | 0.200 |
Why?
|
| Office Visits | 2 | 2004 | 593 | 0.200 |
Why?
|
| Lipoproteins | 5 | 2023 | 879 | 0.200 |
Why?
|
| Health Services | 5 | 1999 | 751 | 0.200 |
Why?
|
| Patients | 2 | 1999 | 906 | 0.200 |
Why?
|
| Diet Surveys | 3 | 2021 | 1161 | 0.200 |
Why?
|
| Longitudinal Studies | 14 | 2022 | 14599 | 0.200 |
Why?
|
| Adipocytes | 3 | 2023 | 1187 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 2 | 2019 | 4408 | 0.190 |
Why?
|
| Regression Analysis | 11 | 2015 | 6339 | 0.190 |
Why?
|
| Diet, Fat-Restricted | 2 | 2014 | 329 | 0.190 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2023 | 215 | 0.190 |
Why?
|
| Genetics, Population | 3 | 2017 | 935 | 0.190 |
Why?
|
| Medicine | 3 | 1998 | 942 | 0.190 |
Why?
|
| Self Report | 7 | 2022 | 3727 | 0.190 |
Why?
|
| Protein Kinases | 1 | 2008 | 1606 | 0.180 |
Why?
|
| Body Size | 2 | 2015 | 463 | 0.180 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2016 | 295 | 0.180 |
Why?
|
| Photoperiod | 1 | 2021 | 139 | 0.180 |
Why?
|
| Medical History Taking | 2 | 2017 | 773 | 0.180 |
Why?
|
| Expert Testimony | 2 | 2020 | 364 | 0.180 |
Why?
|
| Abortifacient Agents, Steroidal | 2 | 1999 | 22 | 0.180 |
Why?
|
| Follistatin | 1 | 2021 | 137 | 0.180 |
Why?
|
| Hip | 2 | 2013 | 255 | 0.180 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 393 | 0.180 |
Why?
|
| Wrist | 2 | 2013 | 226 | 0.180 |
Why?
|
| Haplotypes | 8 | 2022 | 2713 | 0.180 |
Why?
|
| Respiratory System | 1 | 2004 | 563 | 0.180 |
Why?
|
| Pharmacogenetics | 2 | 2017 | 675 | 0.180 |
Why?
|
| Fitness Centers | 1 | 2020 | 13 | 0.180 |
Why?
|
| Carrier Proteins | 1 | 2013 | 4937 | 0.180 |
Why?
|
| Uterine Neoplasms | 1 | 2009 | 1420 | 0.180 |
Why?
|
| Rural Health | 3 | 1991 | 296 | 0.180 |
Why?
|
| Minority Groups | 4 | 2022 | 1202 | 0.180 |
Why?
|
| Islets of Langerhans | 3 | 2023 | 1340 | 0.180 |
Why?
|
| Sample Size | 3 | 2022 | 838 | 0.180 |
Why?
|
| Genetic Pleiotropy | 2 | 2022 | 181 | 0.170 |
Why?
|
| Population Surveillance | 3 | 2019 | 2597 | 0.170 |
Why?
|
| Health Plan Implementation | 2 | 2020 | 335 | 0.170 |
Why?
|
| Gastrointestinal Transit | 1 | 2021 | 100 | 0.170 |
Why?
|
| Hyperlipidemias | 2 | 2023 | 770 | 0.170 |
Why?
|
| Family Health | 2 | 2012 | 1253 | 0.170 |
Why?
|
| Insurance, Health | 7 | 2001 | 2495 | 0.170 |
Why?
|
| Genome, Human | 7 | 2022 | 4421 | 0.170 |
Why?
|
| Heredity | 2 | 2019 | 148 | 0.170 |
Why?
|
| Cardiovascular System | 2 | 2020 | 834 | 0.170 |
Why?
|
| Managed Care Programs | 3 | 2000 | 937 | 0.170 |
Why?
|
| Arteries | 1 | 2005 | 1120 | 0.170 |
Why?
|
| Genetics | 1 | 2020 | 114 | 0.170 |
Why?
|
| Inflammation Mediators | 3 | 2012 | 1884 | 0.170 |
Why?
|
| Mifepristone | 2 | 1999 | 151 | 0.170 |
Why?
|
| Exercise Tolerance | 1 | 2005 | 836 | 0.170 |
Why?
|
| Telephone | 2 | 2001 | 626 | 0.170 |
Why?
|
| Equilibrative Nucleoside Transport Proteins | 1 | 2019 | 2 | 0.170 |
Why?
|
| Organic Cation Transporter 1 | 1 | 2019 | 8 | 0.170 |
Why?
|
| Nurse's Role | 1 | 2001 | 188 | 0.170 |
Why?
|
| Family | 5 | 2014 | 3193 | 0.160 |
Why?
|
| Serum | 1 | 2020 | 208 | 0.160 |
Why?
|
| Coronary Disease | 4 | 2016 | 5911 | 0.160 |
Why?
|
| Dietary Fiber | 3 | 2020 | 758 | 0.160 |
Why?
|
| Proinsulin | 2 | 2011 | 135 | 0.160 |
Why?
|
| Glycemic Index | 1 | 2021 | 396 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2003 | 1250 | 0.160 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 858 | 0.160 |
Why?
|
| Patient Satisfaction | 7 | 2001 | 3451 | 0.160 |
Why?
|
| Women's Health | 3 | 2017 | 2066 | 0.160 |
Why?
|
| Child | 32 | 2021 | 80089 | 0.160 |
Why?
|
| Linear Models | 9 | 2016 | 5866 | 0.160 |
Why?
|
| Computational Biology | 3 | 2020 | 3509 | 0.160 |
Why?
|
| Lactase | 1 | 2019 | 71 | 0.160 |
Why?
|
| Dentition, Permanent | 1 | 2018 | 22 | 0.160 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 557 | 0.160 |
Why?
|
| Reproducibility of Results | 17 | 2022 | 20077 | 0.160 |
Why?
|
| Menopause | 3 | 2022 | 1645 | 0.160 |
Why?
|
| Financial Management | 1 | 2020 | 160 | 0.160 |
Why?
|
| Stomatitis, Aphthous | 1 | 2019 | 51 | 0.160 |
Why?
|
| Parents | 2 | 2019 | 3563 | 0.160 |
Why?
|
| Patient Simulation | 1 | 2001 | 298 | 0.160 |
Why?
|
| Models, Biological | 10 | 2020 | 9461 | 0.160 |
Why?
|
| Models, Statistical | 5 | 2020 | 5074 | 0.150 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 2 | 2017 | 126 | 0.150 |
Why?
|
| Logistic Models | 6 | 2015 | 13248 | 0.150 |
Why?
|
| Transcription, Genetic | 3 | 2015 | 7583 | 0.150 |
Why?
|
| ROC Curve | 2 | 2020 | 3575 | 0.150 |
Why?
|
| Oral Ulcer | 1 | 2019 | 96 | 0.150 |
Why?
|
| Tooth | 1 | 2020 | 210 | 0.150 |
Why?
|
| Medically Uninsured | 3 | 1993 | 835 | 0.150 |
Why?
|
| Multivariate Analysis | 11 | 2016 | 12043 | 0.150 |
Why?
|
| Societies, Medical | 2 | 2020 | 3901 | 0.150 |
Why?
|
| Movement | 4 | 2013 | 1476 | 0.150 |
Why?
|
| Glucose-6-Phosphatase | 2 | 2015 | 72 | 0.150 |
Why?
|
| Fast Foods | 1 | 2020 | 210 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2021 | 504 | 0.150 |
Why?
|
| Arizona | 3 | 2007 | 107 | 0.150 |
Why?
|
| Meat Products | 2 | 2015 | 96 | 0.150 |
Why?
|
| Hemochromatosis | 1 | 2019 | 174 | 0.150 |
Why?
|
| Education | 1 | 2001 | 534 | 0.150 |
Why?
|
| RNA-Binding Proteins | 4 | 2024 | 1890 | 0.150 |
Why?
|
| Fetal Blood | 2 | 2023 | 1347 | 0.150 |
Why?
|
| Genetic Linkage | 2 | 2016 | 2340 | 0.150 |
Why?
|
| Time Factors | 13 | 2021 | 39908 | 0.150 |
Why?
|
| Medical Audit | 1 | 1999 | 453 | 0.150 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2017 | 602 | 0.150 |
Why?
|
| Fibrinogen | 3 | 2015 | 887 | 0.140 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 3 | 2017 | 152 | 0.140 |
Why?
|
| Nucleotides | 1 | 2020 | 453 | 0.140 |
Why?
|
| Metagenome | 1 | 2021 | 448 | 0.140 |
Why?
|
| Health Care Surveys | 3 | 2001 | 2422 | 0.140 |
Why?
|
| Cell Adhesion Molecules | 3 | 2023 | 1602 | 0.140 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 7995 | 0.140 |
Why?
|
| Carotenoids | 1 | 2020 | 621 | 0.140 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2017 | 240 | 0.140 |
Why?
|
| Artifacts | 2 | 2005 | 1910 | 0.140 |
Why?
|
| Preventive Health Services | 3 | 2019 | 566 | 0.140 |
Why?
|
| Morbidity | 1 | 2022 | 1750 | 0.140 |
Why?
|
| Risk Adjustment | 1 | 2001 | 600 | 0.140 |
Why?
|
| Mitochondrial Proteins | 3 | 2015 | 974 | 0.140 |
Why?
|
| Diet, Reducing | 3 | 2015 | 485 | 0.140 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 2223 | 0.140 |
Why?
|
| Developing Countries | 3 | 2023 | 2868 | 0.140 |
Why?
|
| Siblings | 2 | 2019 | 824 | 0.140 |
Why?
|
| Pedigree | 3 | 2018 | 4539 | 0.140 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 1186 | 0.140 |
Why?
|
| Confidence Intervals | 2 | 2020 | 2925 | 0.130 |
Why?
|
| Tropomyosin | 1 | 2016 | 104 | 0.130 |
Why?
|
| Age Factors | 13 | 2021 | 18381 | 0.130 |
Why?
|
| Tooth Loss | 1 | 2018 | 200 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2011 | 705 | 0.130 |
Why?
|
| Health Services Research | 6 | 2000 | 1808 | 0.130 |
Why?
|
| Trans-Activators | 2 | 2017 | 2851 | 0.130 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.130 |
Why?
|
| Calorimetry | 3 | 2007 | 129 | 0.130 |
Why?
|
| Research Design | 3 | 2024 | 6174 | 0.130 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2021 | 709 | 0.130 |
Why?
|
| alpha-Linolenic Acid | 1 | 2016 | 144 | 0.130 |
Why?
|
| Disease | 1 | 2021 | 670 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 63 | 0.130 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3527 | 0.130 |
Why?
|
| Health Behavior | 5 | 2016 | 2643 | 0.130 |
Why?
|
| Ventricular Dysfunction | 1 | 2016 | 144 | 0.130 |
Why?
|
| Angiopoietins | 1 | 2016 | 85 | 0.130 |
Why?
|
| Exercise Therapy | 3 | 2019 | 929 | 0.130 |
Why?
|
| Lipoprotein Lipase | 1 | 2016 | 133 | 0.130 |
Why?
|
| Methotrexate | 3 | 1997 | 1716 | 0.130 |
Why?
|
| Health Expenditures | 7 | 2000 | 2363 | 0.130 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2015 | 84 | 0.120 |
Why?
|
| Adaptation, Physiological | 2 | 2017 | 1300 | 0.120 |
Why?
|
| Body Weights and Measures | 2 | 2013 | 208 | 0.120 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2017 | 321 | 0.120 |
Why?
|
| Reference Values | 3 | 2020 | 4919 | 0.120 |
Why?
|
| Stroke | 5 | 2020 | 9715 | 0.120 |
Why?
|
| Physician-Patient Relations | 4 | 2001 | 3239 | 0.120 |
Why?
|
| Monitoring, Ambulatory | 2 | 2011 | 355 | 0.120 |
Why?
|
| Psychomotor Performance | 1 | 2003 | 1882 | 0.120 |
Why?
|
| Leisure Activities | 1 | 2016 | 308 | 0.120 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2016 | 225 | 0.120 |
Why?
|
| Postpartum Period | 2 | 2019 | 1178 | 0.120 |
Why?
|
| Coffea | 1 | 2014 | 22 | 0.120 |
Why?
|
| Demography | 2 | 2012 | 1643 | 0.120 |
Why?
|
| Wakefulness | 1 | 2021 | 1264 | 0.120 |
Why?
|
| Diagnosis-Related Groups | 4 | 2000 | 448 | 0.120 |
Why?
|
| Continuity of Patient Care | 1 | 2001 | 1067 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2018 | 10203 | 0.120 |
Why?
|
| Area Under Curve | 3 | 2010 | 1635 | 0.120 |
Why?
|
| Phosphofructokinase-1, Muscle Type | 1 | 2013 | 4 | 0.120 |
Why?
|
| Health Services Accessibility | 4 | 2019 | 5430 | 0.120 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2017 | 92 | 0.120 |
Why?
|
| Seafood | 2 | 2020 | 393 | 0.120 |
Why?
|
| Proline | 2 | 2007 | 455 | 0.110 |
Why?
|
| Fetal Development | 1 | 2019 | 769 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2021 | 2896 | 0.110 |
Why?
|
| Metabolome | 1 | 2020 | 988 | 0.110 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 733 | 0.110 |
Why?
|
| Flavonoids | 2 | 2013 | 445 | 0.110 |
Why?
|
| Flavonols | 1 | 2013 | 85 | 0.110 |
Why?
|
| Patient-Centered Care | 2 | 2020 | 1419 | 0.110 |
Why?
|
| Colposcopy | 1 | 2014 | 149 | 0.110 |
Why?
|
| tRNA Methyltransferases | 2 | 2010 | 51 | 0.110 |
Why?
|
| Exercise Test | 5 | 2013 | 2127 | 0.110 |
Why?
|
| Lysophospholipase | 2 | 2011 | 66 | 0.110 |
Why?
|
| Teaching | 1 | 2001 | 1169 | 0.110 |
Why?
|
| Databases, Factual | 5 | 2019 | 7963 | 0.110 |
Why?
|
| Gynecology | 1 | 1999 | 526 | 0.110 |
Why?
|
| Alanine | 2 | 2007 | 609 | 0.110 |
Why?
|
| Lignans | 1 | 2013 | 84 | 0.110 |
Why?
|
| Oral Health | 1 | 2018 | 492 | 0.100 |
Why?
|
| Social Class | 2 | 2000 | 1993 | 0.100 |
Why?
|
| Receptors, Adiponectin | 1 | 2012 | 81 | 0.100 |
Why?
|
| Hyperinsulinism | 1 | 2015 | 400 | 0.100 |
Why?
|
| Abdominal Fat | 2 | 2011 | 221 | 0.100 |
Why?
|
| Particle Size | 1 | 2016 | 1648 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 2 | 2009 | 70 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1086 | 0.100 |
Why?
|
| Interleukin-6 | 3 | 2023 | 3205 | 0.100 |
Why?
|
| C-Reactive Protein | 3 | 2016 | 3820 | 0.100 |
Why?
|
| Hand | 1 | 2017 | 902 | 0.100 |
Why?
|
| Disease Progression | 7 | 2022 | 13495 | 0.100 |
Why?
|
| Receptors, Notch | 1 | 2016 | 743 | 0.100 |
Why?
|
| Drinking Behavior | 1 | 2012 | 103 | 0.100 |
Why?
|
| Age Distribution | 2 | 2015 | 2872 | 0.100 |
Why?
|
| Aged, 80 and over | 14 | 2022 | 58919 | 0.100 |
Why?
|
| Interviews as Topic | 1 | 1999 | 2697 | 0.100 |
Why?
|
| Anorexia Nervosa | 1 | 2021 | 1361 | 0.100 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2011 | 72 | 0.100 |
Why?
|
| Feces | 3 | 2023 | 1490 | 0.090 |
Why?
|
| Trace Elements | 1 | 2013 | 195 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 1133 | 0.090 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2016 | 851 | 0.090 |
Why?
|
| Caloric Restriction | 1 | 2013 | 299 | 0.090 |
Why?
|
| Nicotine | 1 | 1996 | 679 | 0.090 |
Why?
|
| Counseling | 2 | 2015 | 1538 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2012 | 789 | 0.090 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2001 | 242 | 0.090 |
Why?
|
| Heart | 1 | 2004 | 4403 | 0.090 |
Why?
|
| Neoplasms | 8 | 2023 | 22131 | 0.090 |
Why?
|
| Data Collection | 1 | 2020 | 3316 | 0.090 |
Why?
|
| Community Medicine | 1 | 1990 | 23 | 0.090 |
Why?
|
| Menarche | 1 | 2013 | 532 | 0.090 |
Why?
|
| Bed Rest | 1 | 2010 | 83 | 0.090 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2012 | 224 | 0.090 |
Why?
|
| Alcoholic Beverages | 1 | 2012 | 264 | 0.090 |
Why?
|
| Cervix Uteri | 1 | 2014 | 570 | 0.090 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2018 | 1551 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 1202 | 0.090 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2022 | 1533 | 0.090 |
Why?
|
| Adipogenesis | 3 | 2021 | 366 | 0.090 |
Why?
|
| Public Health | 2 | 2020 | 2671 | 0.090 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2013 | 389 | 0.090 |
Why?
|
| Health Care Costs | 5 | 2014 | 3238 | 0.090 |
Why?
|
| Nutrigenomics | 2 | 2022 | 24 | 0.090 |
Why?
|
| Fetus | 1 | 2017 | 1862 | 0.090 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 40 | 0.090 |
Why?
|
| Metabolism | 1 | 2011 | 193 | 0.090 |
Why?
|
| Drug Hypersensitivity | 1 | 2019 | 917 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2021 | 3688 | 0.090 |
Why?
|
| RNA, Messenger | 4 | 2023 | 12759 | 0.090 |
Why?
|
| Likelihood Functions | 2 | 2007 | 991 | 0.090 |
Why?
|
| Weight-Bearing | 1 | 2012 | 532 | 0.090 |
Why?
|
| Nutrition Surveys | 4 | 2018 | 1725 | 0.090 |
Why?
|
| Attitude of Health Personnel | 2 | 2001 | 3882 | 0.090 |
Why?
|
| Potassium Channels | 3 | 2009 | 537 | 0.090 |
Why?
|
| Gene Regulatory Networks | 2 | 2016 | 1745 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2019 | 1589 | 0.080 |
Why?
|
| Docosahexaenoic Acids | 1 | 2016 | 907 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2020 | 3415 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 3776 | 0.080 |
Why?
|
| Software | 2 | 2021 | 4432 | 0.080 |
Why?
|
| Vaccination | 1 | 2022 | 3370 | 0.080 |
Why?
|
| Activities of Daily Living | 3 | 2013 | 2419 | 0.080 |
Why?
|
| Receptors, Drug | 2 | 2007 | 157 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2018 | 2445 | 0.080 |
Why?
|
| Magnesium | 1 | 2013 | 804 | 0.080 |
Why?
|
| Gestational Age | 3 | 2019 | 3577 | 0.080 |
Why?
|
| Quality of Health Care | 5 | 2000 | 4325 | 0.080 |
Why?
|
| Transcription Factor AP-2 | 1 | 2009 | 78 | 0.080 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2019 | 2518 | 0.080 |
Why?
|
| Cystoscopy | 1 | 2009 | 130 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 2222 | 0.080 |
Why?
|
| Estonia | 4 | 2011 | 56 | 0.080 |
Why?
|
| Hypercholesterolemia | 3 | 2010 | 1141 | 0.080 |
Why?
|
| Blood Pressure Determination | 1 | 1993 | 633 | 0.080 |
Why?
|
| Diet Records | 2 | 2016 | 427 | 0.080 |
Why?
|
| Clonidine | 1 | 1989 | 169 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 2149 | 0.080 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2020 | 39 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2009 | 697 | 0.080 |
Why?
|
| Uric Acid | 1 | 2015 | 806 | 0.080 |
Why?
|
| Fishes | 1 | 2012 | 602 | 0.080 |
Why?
|
| Physical Exertion | 1 | 2001 | 668 | 0.080 |
Why?
|
| Attitude to Health | 4 | 1999 | 2025 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 2234 | 0.080 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2007 | 144 | 0.080 |
Why?
|
| Membrane Transport Proteins | 3 | 2016 | 1034 | 0.080 |
Why?
|
| Circadian Rhythm | 2 | 2023 | 2569 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2001 | 4010 | 0.080 |
Why?
|
| Nutrition Assessment | 3 | 2019 | 726 | 0.080 |
Why?
|
| Lipase | 1 | 2010 | 324 | 0.080 |
Why?
|
| Random Allocation | 3 | 2017 | 2392 | 0.080 |
Why?
|
| Disease Susceptibility | 2 | 2019 | 1788 | 0.080 |
Why?
|
| Carbonated Beverages | 3 | 2016 | 210 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2456 | 0.080 |
Why?
|
| Primary Prevention | 1 | 2015 | 1185 | 0.080 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2022 | 793 | 0.070 |
Why?
|
| Models, Genetic | 2 | 2016 | 3431 | 0.070 |
Why?
|
| Internal Medicine | 3 | 2001 | 1051 | 0.070 |
Why?
|
| Cause of Death | 3 | 2017 | 3683 | 0.070 |
Why?
|
| Causality | 3 | 2023 | 1241 | 0.070 |
Why?
|
| Algorithms | 3 | 2023 | 14024 | 0.070 |
Why?
|
| Infant | 7 | 2021 | 36157 | 0.070 |
Why?
|
| Atherosclerosis | 2 | 2022 | 3400 | 0.070 |
Why?
|
| Economics, Medical | 2 | 1998 | 112 | 0.070 |
Why?
|
| Child, Preschool | 9 | 2018 | 42193 | 0.070 |
Why?
|
| Nurses | 1 | 2017 | 2477 | 0.070 |
Why?
|
| Animals | 15 | 2023 | 168202 | 0.070 |
Why?
|
| Placebos | 2 | 2012 | 1667 | 0.070 |
Why?
|
| Poverty | 2 | 1997 | 2692 | 0.070 |
Why?
|
| Drosophila Proteins | 1 | 2016 | 1698 | 0.070 |
Why?
|
| Antiporters | 2 | 2019 | 276 | 0.070 |
Why?
|
| Health Promotion | 1 | 2019 | 2206 | 0.070 |
Why?
|
| Pregnancy Complications | 3 | 2019 | 2948 | 0.070 |
Why?
|
| Zinc | 1 | 2011 | 687 | 0.070 |
Why?
|
| Heart Ventricles | 1 | 2019 | 3796 | 0.070 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 1987 | 41 | 0.070 |
Why?
|
| Oxidoreductases | 1 | 2009 | 412 | 0.070 |
Why?
|
| Health Policy | 3 | 1997 | 2682 | 0.070 |
Why?
|
| Clinical Competence | 2 | 2001 | 4790 | 0.070 |
Why?
|
| Milk | 2 | 2020 | 442 | 0.070 |
Why?
|
| Pandemics | 3 | 2023 | 8652 | 0.070 |
Why?
|
| TCF Transcription Factors | 1 | 2007 | 138 | 0.070 |
Why?
|
| Satiety Response | 1 | 2006 | 47 | 0.070 |
Why?
|
| Echocardiography | 1 | 2019 | 4987 | 0.070 |
Why?
|
| Hospital Departments | 1 | 1987 | 134 | 0.070 |
Why?
|
| Diabetic Angiopathies | 1 | 2011 | 803 | 0.070 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1990 | 537 | 0.070 |
Why?
|
| Chronic Disease | 5 | 2017 | 9310 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2252 | 0.070 |
Why?
|
| Diastole | 2 | 2019 | 781 | 0.070 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2007 | 563 | 0.070 |
Why?
|
| Cluster Analysis | 3 | 2021 | 2703 | 0.070 |
Why?
|
| Japan | 1 | 2010 | 1372 | 0.070 |
Why?
|
| CpG Islands | 1 | 2010 | 1192 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 2 | 1999 | 3196 | 0.070 |
Why?
|
| Liver | 2 | 2019 | 7512 | 0.070 |
Why?
|
| Lamin Type A | 1 | 2007 | 186 | 0.060 |
Why?
|
| Germany | 2 | 2018 | 872 | 0.060 |
Why?
|
| Peptide YY | 1 | 2006 | 135 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2008 | 428 | 0.060 |
Why?
|
| Transferrin | 2 | 2017 | 283 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2023 | 11512 | 0.060 |
Why?
|
| Deuterium | 1 | 2005 | 106 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2018 | 2778 | 0.060 |
Why?
|
| Running | 3 | 2007 | 488 | 0.060 |
Why?
|
| Prognosis | 4 | 2021 | 29601 | 0.060 |
Why?
|
| Principal Component Analysis | 2 | 2019 | 943 | 0.060 |
Why?
|
| Tuberculin Test | 1 | 1985 | 206 | 0.060 |
Why?
|
| Twins, Dizygotic | 1 | 2005 | 236 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2012 | 2916 | 0.060 |
Why?
|
| gamma-Glutamyltransferase | 2 | 2016 | 144 | 0.060 |
Why?
|
| Pakistan | 2 | 2015 | 292 | 0.060 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1990 | 951 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2016 | 3567 | 0.060 |
Why?
|
| Genetics, Medical | 1 | 2007 | 334 | 0.060 |
Why?
|
| Reproductive History | 2 | 2018 | 210 | 0.060 |
Why?
|
| Myocardial Infarction | 3 | 2018 | 11458 | 0.060 |
Why?
|
| Comorbidity | 2 | 2016 | 10507 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2851 | 0.060 |
Why?
|
| Pregnancy in Diabetics | 1 | 2006 | 197 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 1996 | 2056 | 0.060 |
Why?
|
| Obstetrics | 2 | 1991 | 666 | 0.060 |
Why?
|
| Epigenomics | 2 | 2022 | 942 | 0.060 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 9417 | 0.060 |
Why?
|
| Ferritins | 2 | 2017 | 597 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 1608 | 0.060 |
Why?
|
| Twins, Monozygotic | 1 | 2005 | 470 | 0.060 |
Why?
|
| Hunger | 2 | 2021 | 205 | 0.060 |
Why?
|
| Jet Lag Syndrome | 1 | 2023 | 24 | 0.060 |
Why?
|
| Spain | 1 | 2005 | 487 | 0.050 |
Why?
|
| Mass Screening | 3 | 1993 | 5425 | 0.050 |
Why?
|
| Ketone Bodies | 1 | 2023 | 76 | 0.050 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2017 | 263 | 0.050 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2006 | 582 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 5334 | 0.050 |
Why?
|
| Treatment Outcome | 7 | 2023 | 64572 | 0.050 |
Why?
|
| Locomotion | 1 | 2005 | 388 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2023 | 6826 | 0.050 |
Why?
|
| Stress, Psychological | 2 | 1997 | 4488 | 0.050 |
Why?
|
| Physiology | 1 | 2003 | 111 | 0.050 |
Why?
|
| Phylogeny | 1 | 2010 | 2805 | 0.050 |
Why?
|
| Walking | 3 | 2007 | 1197 | 0.050 |
Why?
|
| Erythrocytes | 1 | 2012 | 2410 | 0.050 |
Why?
|
| Elasticity | 1 | 2005 | 655 | 0.050 |
Why?
|
| Repressor Proteins | 2 | 2017 | 2985 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2016 | 4110 | 0.050 |
Why?
|
| Glycine | 1 | 2006 | 661 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 1 | 2023 | 239 | 0.050 |
Why?
|
| Physical Endurance | 1 | 2005 | 366 | 0.050 |
Why?
|
| Abdomen | 1 | 2008 | 1128 | 0.050 |
Why?
|
| Alanine Transaminase | 2 | 2016 | 601 | 0.050 |
Why?
|
| Lysine | 1 | 2007 | 993 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
| Communicable Diseases | 1 | 2010 | 871 | 0.050 |
Why?
|
| Fatty Acids, Volatile | 1 | 2023 | 103 | 0.050 |
Why?
|
| Survival Analysis | 4 | 2000 | 10072 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2012 | 2565 | 0.050 |
Why?
|
| Mammography | 1 | 1993 | 2430 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 3 | 1998 | 1723 | 0.050 |
Why?
|
| Serine | 1 | 2006 | 830 | 0.050 |
Why?
|
| Africa | 1 | 2024 | 714 | 0.050 |
Why?
|
| Policy Making | 2 | 1997 | 541 | 0.050 |
Why?
|
| Glycoproteins | 2 | 2021 | 2200 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3245 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2024 | 898 | 0.050 |
Why?
|
| England | 2 | 2020 | 526 | 0.050 |
Why?
|
| GATA5 Transcription Factor | 1 | 2020 | 18 | 0.050 |
Why?
|
| Drug Therapy, Combination | 5 | 2016 | 6305 | 0.050 |
Why?
|
| Bread | 1 | 2020 | 23 | 0.050 |
Why?
|
| Pilot Projects | 3 | 2018 | 8619 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2021 | 183 | 0.050 |
Why?
|
| Phospholipase C beta | 1 | 2020 | 49 | 0.050 |
Why?
|
| Satiation | 1 | 2021 | 82 | 0.050 |
Why?
|
| Bacteroidetes | 1 | 2021 | 83 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 13442 | 0.050 |
Why?
|
| Prevotella | 1 | 2021 | 80 | 0.050 |
Why?
|
| Food Microbiology | 1 | 2021 | 74 | 0.050 |
Why?
|
| Pancreatic Function Tests | 1 | 2021 | 69 | 0.050 |
Why?
|
| Oxygenases | 1 | 2020 | 59 | 0.050 |
Why?
|
| Video Games | 1 | 2003 | 197 | 0.050 |
Why?
|
| Blastocystis | 1 | 2021 | 21 | 0.050 |
Why?
|
| Drosophila | 2 | 2019 | 1494 | 0.050 |
Why?
|
| Population Groups | 1 | 2021 | 207 | 0.040 |
Why?
|
| Mutation, Missense | 3 | 2017 | 2570 | 0.040 |
Why?
|
| Vagus Nerve | 1 | 2003 | 458 | 0.040 |
Why?
|
| Bacteroides | 1 | 2021 | 165 | 0.040 |
Why?
|
| Puerto Rico | 1 | 2021 | 378 | 0.040 |
Why?
|
| Administration, Intravaginal | 2 | 1999 | 149 | 0.040 |
Why?
|
| Yogurt | 1 | 2020 | 71 | 0.040 |
Why?
|
| Mice | 7 | 2023 | 81368 | 0.040 |
Why?
|
| Fractures, Bone | 1 | 2012 | 2045 | 0.040 |
Why?
|
| Physicians | 1 | 1998 | 4583 | 0.040 |
Why?
|
| Ontario | 1 | 2001 | 397 | 0.040 |
Why?
|
| Sentinel Surveillance | 1 | 2022 | 291 | 0.040 |
Why?
|
| Empirical Research | 1 | 2000 | 120 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2019 | 25 | 0.040 |
Why?
|
| Censuses | 1 | 2001 | 198 | 0.040 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 2 | 2011 | 158 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2017 | 1650 | 0.040 |
Why?
|
| Receptors, CCR2 | 1 | 2020 | 214 | 0.040 |
Why?
|
| RNA Interference | 1 | 2008 | 2829 | 0.040 |
Why?
|
| Australia | 1 | 2023 | 1249 | 0.040 |
Why?
|
| Self Administration | 2 | 1999 | 387 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6473 | 0.040 |
Why?
|
| Receptors, Vasopressin | 1 | 2019 | 105 | 0.040 |
Why?
|
| Molar | 1 | 2020 | 156 | 0.040 |
Why?
|
| Caspase 9 | 1 | 2019 | 184 | 0.040 |
Why?
|
| Retrospective Studies | 8 | 2021 | 80583 | 0.040 |
Why?
|
| Rural Population | 1 | 1990 | 2277 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2019 | 5239 | 0.040 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1985 | 831 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1697 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2022 | 373 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15829 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2023 | 829 | 0.040 |
Why?
|
| Infant, Newborn | 8 | 2021 | 26183 | 0.040 |
Why?
|
| Acetylation | 1 | 2021 | 1055 | 0.040 |
Why?
|
| DMF Index | 1 | 2018 | 87 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2000 | 615 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2023 | 3769 | 0.040 |
Why?
|
| Individuality | 1 | 2020 | 301 | 0.040 |
Why?
|
| Research Personnel | 1 | 2023 | 588 | 0.040 |
Why?
|
| Gene Expression | 3 | 2021 | 7569 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2021 | 562 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 1983 | 697 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 2020 | 486 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2010 | 5965 | 0.040 |
Why?
|
| Periodontal Index | 1 | 2018 | 151 | 0.040 |
Why?
|
| Mutation | 3 | 2020 | 30015 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2019 | 613 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 2003 | 1515 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2023 | 1172 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 3 | 1997 | 908 | 0.040 |
Why?
|
| Reminder Systems | 1 | 2001 | 386 | 0.040 |
Why?
|
| Medical Record Linkage | 1 | 1999 | 286 | 0.040 |
Why?
|
| Caveolin 2 | 1 | 2017 | 25 | 0.040 |
Why?
|
| Laboratories, Hospital | 1 | 1999 | 190 | 0.040 |
Why?
|
| Dipeptidases | 1 | 2017 | 38 | 0.040 |
Why?
|
| Therapeutic Irrigation | 1 | 1998 | 289 | 0.040 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 14 | 0.040 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2017 | 141 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 13635 | 0.040 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2017 | 19 | 0.040 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2017 | 135 | 0.040 |
Why?
|
| Metagenomics | 1 | 2021 | 463 | 0.040 |
Why?
|
| Glucokinase | 1 | 2017 | 102 | 0.040 |
Why?
|
| Databases, Genetic | 2 | 2017 | 1742 | 0.040 |
Why?
|
| Health | 1 | 1980 | 398 | 0.040 |
Why?
|
| Appointments and Schedules | 1 | 2001 | 442 | 0.040 |
Why?
|
| Reference Standards | 1 | 2020 | 1003 | 0.030 |
Why?
|
| Norway | 2 | 2011 | 499 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 3447 | 0.030 |
Why?
|
| Respiration | 1 | 2003 | 1656 | 0.030 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2017 | 60 | 0.030 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2016 | 60 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2001 | 992 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2023 | 1013 | 0.030 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2016 | 42 | 0.030 |
Why?
|
| Hospitals, Community | 1 | 1999 | 365 | 0.030 |
Why?
|
| Iceland | 1 | 2016 | 184 | 0.030 |
Why?
|
| Somatomedins | 1 | 2017 | 179 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2017 | 174 | 0.030 |
Why?
|
| Aging | 2 | 2006 | 8700 | 0.030 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2016 | 48 | 0.030 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2016 | 108 | 0.030 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2016 | 91 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2018 | 583 | 0.030 |
Why?
|
| Access to Information | 1 | 2019 | 316 | 0.030 |
Why?
|
| Mouth Diseases | 1 | 2018 | 241 | 0.030 |
Why?
|
| Rest | 2 | 2015 | 918 | 0.030 |
Why?
|
| Poverty Areas | 1 | 1997 | 263 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 470 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2006 | 14649 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2020 | 802 | 0.030 |
Why?
|
| Systole | 1 | 2018 | 935 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 841 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 2001 | 825 | 0.030 |
Why?
|
| Electrocardiography | 2 | 2005 | 6346 | 0.030 |
Why?
|
| Uterine Hemorrhage | 1 | 1997 | 240 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2017 | 261 | 0.030 |
Why?
|
| Base Sequence | 1 | 2006 | 12420 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 3 | 1998 | 5493 | 0.030 |
Why?
|
| Insurance Claim Review | 1 | 2000 | 741 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2019 | 580 | 0.030 |
Why?
|
| Receptors, Somatostatin | 1 | 2016 | 136 | 0.030 |
Why?
|
| Serum Amyloid A Protein | 1 | 2015 | 126 | 0.030 |
Why?
|
| Margarine | 1 | 2014 | 17 | 0.030 |
Why?
|
| Professional Practice | 1 | 1997 | 313 | 0.030 |
Why?
|
| Butter | 1 | 2014 | 22 | 0.030 |
Why?
|
| Fats | 1 | 2015 | 99 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 8603 | 0.030 |
Why?
|
| Netherlands | 1 | 2020 | 2222 | 0.030 |
Why?
|
| Cognition | 1 | 2012 | 6988 | 0.030 |
Why?
|
| Culture | 1 | 1999 | 623 | 0.030 |
Why?
|
| Multigene Family | 1 | 2018 | 1076 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2001 | 934 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 3634 | 0.030 |
Why?
|
| Medical Staff, Hospital | 1 | 1999 | 601 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2014 | 69 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 289 | 0.030 |
Why?
|
| Brazil | 1 | 2019 | 1229 | 0.030 |
Why?
|
| Periodontal Diseases | 1 | 2018 | 451 | 0.030 |
Why?
|
| Cell Line | 2 | 2023 | 15577 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2021 | 1231 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2023 | 2838 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 36401 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2023 | 2115 | 0.030 |
Why?
|
| HIV Infections | 1 | 2001 | 17342 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2021 | 23415 | 0.030 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 250 | 0.030 |
Why?
|
| Proanthocyanidins | 1 | 2013 | 20 | 0.030 |
Why?
|
| Deuterium Oxide | 1 | 2013 | 34 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2016 | 2185 | 0.030 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 2413 | 0.030 |
Why?
|
| Simvastatin | 1 | 2016 | 346 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 1066 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2000 | 1038 | 0.030 |
Why?
|
| Oxygen Isotopes | 1 | 2013 | 43 | 0.030 |
Why?
|
| Urine | 1 | 2015 | 362 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2017 | 607 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2016 | 488 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 1996 | 712 | 0.030 |
Why?
|
| Plant Oils | 1 | 2014 | 198 | 0.030 |
Why?
|
| Glucose Clamp Technique | 1 | 2014 | 262 | 0.030 |
Why?
|
| DNA | 1 | 2007 | 7196 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 1998 | 869 | 0.030 |
Why?
|
| Scotland | 1 | 2013 | 143 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 2802 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 1033 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2017 | 803 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 1074 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 748 | 0.030 |
Why?
|
| Aminopeptidases | 1 | 2013 | 95 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 1152 | 0.030 |
Why?
|
| Fabaceae | 1 | 2013 | 103 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2022 | 2174 | 0.030 |
Why?
|
| Heart Conduction System | 1 | 2018 | 992 | 0.030 |
Why?
|
| Gravitation | 1 | 2013 | 82 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 520 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 1997 | 645 | 0.030 |
Why?
|
| Vagina | 1 | 1998 | 841 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 852 | 0.030 |
Why?
|
| Calibration | 2 | 2007 | 817 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 1999 | 2358 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2001 | 2486 | 0.030 |
Why?
|
| Research Report | 1 | 2016 | 367 | 0.030 |
Why?
|
| Nuts | 1 | 2014 | 264 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 1983 | 2756 | 0.030 |
Why?
|
| Urban Population | 1 | 2000 | 2034 | 0.030 |
Why?
|
| Television | 1 | 2015 | 407 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 1130 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2017 | 768 | 0.020 |
Why?
|
| Plant Roots | 1 | 2012 | 117 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 318 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 1388 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 139 | 0.020 |
Why?
|
| Plant Leaves | 1 | 2012 | 150 | 0.020 |
Why?
|
| Methylene Chloride | 1 | 1991 | 11 | 0.020 |
Why?
|
| Iron, Dietary | 1 | 2012 | 148 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2021 | 1452 | 0.020 |
Why?
|
| Glycerol | 1 | 2012 | 275 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
| Lipolysis | 1 | 2012 | 211 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2012 | 659 | 0.020 |
Why?
|
| Syndrome | 1 | 2017 | 3268 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2015 | 8516 | 0.020 |
Why?
|
| Recreation | 1 | 2011 | 125 | 0.020 |
Why?
|
| Mitochondria, Muscle | 1 | 2012 | 172 | 0.020 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2016 | 1111 | 0.020 |
Why?
|
| Mitral Valve | 1 | 2019 | 1464 | 0.020 |
Why?
|
| Beer | 1 | 2011 | 134 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3798 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2013 | 290 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2014 | 673 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2017 | 1079 | 0.020 |
Why?
|
| Chromatin | 1 | 2022 | 2955 | 0.020 |
Why?
|
| Hemeproteins | 1 | 2010 | 61 | 0.020 |
Why?
|
| Proteome | 1 | 2020 | 1857 | 0.020 |
Why?
|
| Longevity | 1 | 1998 | 1064 | 0.020 |
Why?
|
| Health Services Misuse | 1 | 1992 | 244 | 0.020 |
Why?
|
| Wine | 1 | 2011 | 166 | 0.020 |
Why?
|
| Malnutrition | 1 | 2017 | 622 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2021 | 4140 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3410 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 469 | 0.020 |
Why?
|
| Popliteal Vein | 1 | 1990 | 43 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 2017 | 1008 | 0.020 |
Why?
|
| Patient Advocacy | 1 | 1992 | 360 | 0.020 |
Why?
|
| Cost Control | 1 | 1992 | 627 | 0.020 |
Why?
|
| Patient Education as Topic | 2 | 2011 | 2315 | 0.020 |
Why?
|
| Actins | 1 | 2017 | 2051 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 491 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2016 | 12333 | 0.020 |
Why?
|
| Femoral Vein | 1 | 1990 | 153 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 1990 | 426 | 0.020 |
Why?
|
| Registries | 2 | 2018 | 8209 | 0.020 |
Why?
|
| Epinephrine | 1 | 2012 | 792 | 0.020 |
Why?
|
| France | 1 | 2010 | 492 | 0.020 |
Why?
|
| Community Health Centers | 1 | 1993 | 460 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2015 | 1175 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 2803 | 0.020 |
Why?
|
| Water | 1 | 2015 | 1409 | 0.020 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2009 | 77 | 0.020 |
Why?
|
| Patient Compliance | 2 | 2009 | 2688 | 0.020 |
Why?
|
| Biological Transport | 1 | 2013 | 2089 | 0.020 |
Why?
|
| Polytetrafluoroethylene | 1 | 1990 | 245 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2019 | 4160 | 0.020 |
Why?
|
| Colon | 1 | 2017 | 1791 | 0.020 |
Why?
|
| Prejudice | 1 | 1993 | 571 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2009 | 210 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3879 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2000 | 1937 | 0.020 |
Why?
|
| Mental Recall | 1 | 2014 | 1222 | 0.020 |
Why?
|
| Labor, Obstetric | 1 | 1991 | 323 | 0.020 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2010 | 262 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1349 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2020 | 3412 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 1712 | 0.020 |
Why?
|
| Depression | 2 | 1997 | 8132 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 865 | 0.020 |
Why?
|
| Nuclear Family | 1 | 2008 | 311 | 0.020 |
Why?
|
| Physical Examination | 2 | 2004 | 1254 | 0.020 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2008 | 166 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 1989 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 6051 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2015 | 1723 | 0.020 |
Why?
|
| Physicians, Women | 1 | 1993 | 509 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 20556 | 0.020 |
Why?
|
| Kidney | 1 | 2022 | 7044 | 0.020 |
Why?
|
| Medicaid | 2 | 1997 | 2814 | 0.020 |
Why?
|
| Robotics | 1 | 2013 | 817 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 1997 | 2768 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2010 | 1972 | 0.020 |
Why?
|
| Behavior | 1 | 2009 | 540 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 1996 | 1999 | 0.020 |
Why?
|
| Body Constitution | 1 | 2006 | 273 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 6223 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2020 | 2423 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2016 | 2118 | 0.020 |
Why?
|
| Physician's Role | 1 | 1992 | 917 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 1993 | 20988 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2019 | 5486 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2019 | 6233 | 0.020 |
Why?
|
| Synapses | 1 | 2015 | 1754 | 0.020 |
Why?
|
| Birth Injuries | 1 | 1987 | 151 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 3607 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 1990 | 1335 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 4739 | 0.020 |
Why?
|
| Sternum | 1 | 2005 | 175 | 0.010 |
Why?
|
| International Cooperation | 1 | 2011 | 1422 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1990 | 1700 | 0.010 |
Why?
|
| Portugal | 1 | 2004 | 91 | 0.010 |
Why?
|
| Skinfold Thickness | 1 | 2004 | 163 | 0.010 |
Why?
|
| Peptides | 1 | 2016 | 4354 | 0.010 |
Why?
|
| Hip Fractures | 1 | 2012 | 988 | 0.010 |
Why?
|
| Delivery, Obstetric | 1 | 1991 | 939 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 2005 | 253 | 0.010 |
Why?
|
| Ribs | 1 | 2005 | 252 | 0.010 |
Why?
|
| Medical Records | 1 | 1989 | 1408 | 0.010 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2003 | 61 | 0.010 |
Why?
|
| HIV Seropositivity | 1 | 1989 | 959 | 0.010 |
Why?
|
| Exons | 1 | 2009 | 2381 | 0.010 |
Why?
|
| SOS1 Protein | 1 | 2003 | 40 | 0.010 |
Why?
|
| Calorimetry, Indirect | 1 | 2004 | 174 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2003 | 329 | 0.010 |
Why?
|
| Health Education | 1 | 1990 | 1049 | 0.010 |
Why?
|
| Electrodes | 1 | 2005 | 610 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2005 | 516 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1996 | 4172 | 0.010 |
Why?
|
| Homozygote | 1 | 2008 | 1776 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 1135 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8426 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5109 | 0.010 |
Why?
|
| Costs and Cost Analysis | 2 | 1992 | 1663 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5789 | 0.010 |
Why?
|
| Host-Pathogen Interactions | 1 | 2010 | 1454 | 0.010 |
Why?
|
| Infant Mortality | 1 | 1987 | 751 | 0.010 |
Why?
|
| Anxiety | 1 | 1997 | 4573 | 0.010 |
Why?
|
| Mothers | 1 | 2012 | 2194 | 0.010 |
Why?
|
| Asthma | 1 | 2020 | 6234 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 10175 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 3419 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 18937 | 0.010 |
Why?
|
| Ion Channels | 1 | 2005 | 1039 | 0.010 |
Why?
|
| Insurance, Major Medical | 1 | 2000 | 12 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1983 | 1624 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4810 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 2003 | 836 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 22117 | 0.010 |
Why?
|
| Financing, Government | 1 | 1983 | 472 | 0.010 |
Why?
|
| Medicare | 1 | 1997 | 6774 | 0.010 |
Why?
|
| Internship and Residency | 1 | 1999 | 5878 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 4172 | 0.010 |
Why?
|
| Gait | 1 | 2003 | 811 | 0.010 |
Why?
|
| Drug Administration Schedule | 2 | 1996 | 4845 | 0.010 |
Why?
|
| Family Planning Services | 1 | 1980 | 266 | 0.010 |
Why?
|
| Quality Control | 1 | 2000 | 831 | 0.010 |
Why?
|
| Air Pollutants | 1 | 1991 | 2893 | 0.010 |
Why?
|
| Uterus | 1 | 1999 | 649 | 0.010 |
Why?
|
| History, 20th Century | 1 | 1983 | 2764 | 0.010 |
Why?
|
| Abortion, Legal | 1 | 1996 | 113 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 1983 | 1204 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2863 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 1 | 1995 | 457 | 0.010 |
Why?
|
| Episiotomy | 1 | 1991 | 21 | 0.010 |
Why?
|
| Fetal Monitoring | 1 | 1991 | 68 | 0.010 |
Why?
|
| State Medicine | 1 | 1993 | 216 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1999 | 4010 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 1999 | 1661 | 0.010 |
Why?
|
| Labor, Induced | 1 | 1991 | 151 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 1998 | 1400 | 0.010 |
Why?
|
| Maternal Age | 1 | 1991 | 809 | 0.000 |
Why?
|
| Pregnancy Outcome | 1 | 1999 | 2921 | 0.000 |
Why?
|
| Federal Government | 1 | 1989 | 267 | 0.000 |
Why?
|
| Posture | 1 | 1991 | 956 | 0.000 |
Why?
|
| Antihypertensive Agents | 1 | 1997 | 2018 | 0.000 |
Why?
|
| Resource Allocation | 1 | 1989 | 350 | 0.000 |
Why?
|
| Cost of Illness | 1 | 1993 | 1937 | 0.000 |
Why?
|
| Hospitalization | 1 | 1996 | 10708 | 0.000 |
Why?
|